Interesting quote I read in regards to side effects of IOLs
Posted , 5 users are following.
I was trying to see if the patient can do certain things to reduce PCO. But in the article I read the following quote:
“Virtually every available IOL design has its specific set of unwanted visual effects, but some designs are better than others in reducing dysphotopsia,” said Steven H. Dewey, MD, who practices in Colorado Springs, Colo.
It's interesting to see a surgeon say this because I feel the unwanted visual effects of IOLs are not talked about enough before surgery by surgeons.
Anyways, was just a little rant.
1 like, 4 replies
RonAKA kevin77191
Posted
On PCO some believe the material used in the AcrySof lenses are more resistant to PCO. Alcon have some studies which seem to back that up. However, I have read elsewhere that Alcon was the first one to use the sharp edge design lens, and that is what is responsible for the PCO reduction...
.
On the dysphotopsia, the monofocal lenses are certainly less affected by it. The multifocal and especially the diffractive ones are most affected.
ad12345 RonAKA
Posted
Do you work for Alcon? Everyone is going to have a PCO sooner or later. Acrysof is as prone as any other lens. It can work for people in their 80s, but not for younger patients. I know some guys with Acrysof and severe PCO 2-3 months after surgery...
RonAKA ad12345
Posted
No I don't work for Alcon. I just do my research. A conclusion from one report:
"Conclusions
Our study reaffirms that lens material and a sharp optic edge design play an important role in reducing Nd:YAG capsulotomy rates. The NMA presents strong evidence to suggest that the risk of Nd:YAG capsulotomy is lower in eyes implanted with AcrySof IOLs compared to non-AcrySof hydrophobic or hydrophilic acrylic IOLs. The appropriate choice of IOL implanted during cataract surgery is an important consideration to reduce the risk of Nd:YAG laser capsulotomy in the post-surgery period and may translate into significant savings for national healthcare systems while at the same time reducing the clinical risks associated with the procedure."
Yes, Alcon was involved in the study, but most of these studies involve one company or another. You can find it by searching for this report.
Effect of AcrySof versus other intraocular lens properties on the risk of Nd:YAG capsulotomy after cataract surgery: A systematic literature review and network meta-analysis Howard Thom,Frank Ender,Saisudha Samavedam,Caridad Perez Vivez,Subhajit Gupta,Mukesh Dhariwal,Jan de Haan,Derek O’Boyle
Sue.An2 kevin77191
Posted
I hear you. But not just cataract surgeons - seems onus is on the patient to research ask questions and be more informed.
Also with IOLs people's tolerances really vary as are expectations which in my opinion are high and will only get higher as people who have had lasik start experiencing first signs of presbyopia.They are accustomed to being glasses free and will want an IOL that keeps them that way.
Some countries like Canada where wait times are high and our medicare system that pays for cataract surgery, the surgeons cannot spend a lit of time going o er every side effect.
Not saying it is right but it is what it is.